Global Health EDCTP3 Joint Undertaking

Afrikaans-Europese partners Verplicht consortium met partners uit beide regio's

Focus op infectieziekten Malaria, tbc, hiv, verwaarloosde of opkomende infectieziekten

Klinische of capacity-building doelen Trials, diagnostiek, vaccinontwikkeling of onderzoekscapaciteit in sub-Sahara-Afrika

Proposals should include one or more clinical trial(s) to be conducted in SSA. The clinical trial(s) must be supported by an appropriate regulatory approval and access strategy and/or include plans for uptake into policy and practice at national or international level.

To be eligible for funding, applicants must be established in one of the following countries: • The Member States of the European Union, including their outermost regions:

Legal entities which are established in countries not listed above (including in low-and middle-income countries that are not members of the EDCTP Association) will be eligible for funding if provided for in … the specific call topic conditions, or if their participation is considered essential for implementing the action by the granting authority.

Unless otherwise provided for in the specific call conditions, for all actions, due to the policy objectives of Global Health EDCTP3, legal entities forming a consortium are eligible to participate in actions under the programme provided that the consortium includes as beneficiaries: • At least three legal entities independent from each other and each established in a different country, where legal entities are eligible to receive funding; • At least one independent legal entity established in a Member State, or in an associated country to Horizon Europe that is a member of the EDCTP Association; and • At least one independent legal entity established in a sub-Saharan African country that is a member of the EDCTP Association.

For the two CSA (2) topics under call HORIZON-JU-GH-EDCTP3-2026-03 in case the applicant consortia opt for including the EDCTP Association as coordinator, the EDCTP Association must not be counted as one of the three independent legal entities necessary to ensure the eligibility of the consortium composition.

where entities established in a third country without an agreement to protect the financial interests of the Union participate with funding in an indirect action, the coordinator of the indirect action must be established in a Member State or associated country, or South Africa.

If the coordinator is not established in a country in SSA (please see previous paragraph), the designation of a scientific project leader established in a SSA country member of the EDCTP Association with the roles as described below is mandatory.